drugset / Trial / NCT00701896

Smoking Cessation Using Motivational Therapy and Varenicline

NCT00701896

Non-randomizedSingle-groupOpen-labelTreatment

Summary

People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized smoking cessation treatment can prevent one from developing accelerated lung damage, particularly emphysema.

Timeline

Start
2008-10-03
Primary completion
2013-04-20
Completion
2013-06-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown Oral
Comparator Varenicline Small molecule 1 mg